RxDoctor Payments Data

Kevin Wess, DO

Family Medicine · Honaker, VANPI 1316061526

Payments from drug & device makers

$575in general payments, 2019–2025

Across 27 payments — averaging $21.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$139
  • AbbVie$82
  • Organogenesis Inc.$63
  • AstraZeneca$62
  • Medline Industries LP$51
  • Molnlycke Health Care US, LLC$49
  • plus $130 from 6 others

What the payments were for

  • Food & beverage$575100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk5$139
AbbVie4$82
Organogenesis Inc.3$63
AstraZeneca4$62
Medline Industries LP2$51
Molnlycke Health Care US, LLC2$49
KCI USA, Inc.2$47
Reapplix Inc.1$29
Solventum Corporation1$15
Polymedics Innovations Inc.1$14
Advanced Oxygen Therapy Inc.1$13
GSK1$12

How this compares

$575 in reported general payments places this provider in the 60th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$45,555
Medicare patients
109
Services billed
685

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SantylCollagenase Clostridium Hist.16$8,216
Vancomycin Hcl17$3,379
Cefepime Hcl12$1,195
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim36$221
Doxycycline Hyclate21$166
Cephalexin16$124
Levofloxacin13$37

Paid to pharmacies, not to this prescriber.

Other family medicine in Honaker

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →